Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

X4 Pharmaceuticals (XFOR) Leases (2019 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Leases for 7 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases fell 60.3% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Sep 2025, down 60.3%, and an annual FY2024 reading of $4.1 million, down 28.05% over the prior year.
  • Leases was $1.8 million for Q3 2025 at X4 Pharmaceuticals, down from $2.6 million in the prior quarter.
  • Across five years, Leases topped out at $9.8 million in Q1 2021 and bottomed at $1.8 million in Q3 2025.
  • Average Leases over 5 years is $6.3 million, with a median of $6.5 million recorded in 2023.
  • The sharpest move saw Leases soared 473.6% in 2021, then plummeted 60.3% in 2025.
  • Year by year, Leases stood at $8.7 million in 2021, then dropped by 17.0% to $7.2 million in 2022, then fell by 21.84% to $5.6 million in 2023, then fell by 28.05% to $4.1 million in 2024, then tumbled by 56.33% to $1.8 million in 2025.
  • Business Quant data shows Leases for XFOR at $1.8 million in Q3 2025, $2.6 million in Q2 2025, and $3.7 million in Q1 2025.